Michael SCHMID

Michael Schmid is a research group leader at the Institute of Translational Medicine, University of Liverpool, UK. He received his PhD from the University of Basel, Switzerland, and completed his postdoctoral training at the Moores Cancer Center, UCSD, USA.

Professor Schmid’s lab performs a research programme on the tumour microenvironment in pancreatic cancer metastasis.  The main goal of his team is to gain a better understanding of where, when and how host immune cells enhance or suppress metastatic progression in pancreatic cancer, with the ultimate aim of identifying new therapeutic possibilities to fight pancreatic cancer.